Skip to main content
OpenTrials

Clinical trial condition

Neurofibromatoses

Explore clinical trials studying Neurofibromatoses. Study availability and eligibility vary by location and protocol.

141 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Neurofibromatoses trial results

Completed

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors

NCT00304083

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, Genetic Diseases, Inborn, +22 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
  • Children's Memorial Hospital - Chicago Chicago, Illinois, United States
  • Indiana University Indianapolis, Indiana, United States
View all 17 locations
View Trial Details
Completed

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

NCT01207687

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +29 more
Locations
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • National Cancer Institute Rockville, Maryland, United States
  • Massachusetts General Hospital Charlestown, Massachusetts, United States
View Trial Details
Completed

Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

NCT00076102

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Childrens National Medical Center Washington D.C., District of Columbia, United States
  • Childrens Memorial Hospital, Chicago Chicago, Illinois, United States
  • Johns Hopkins Oncology Center Baltimore, Maryland, United States
View all 15 locations
View Trial Details
Completed

A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1

NCT00853580

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas

NCT00634270

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
  • National Cancer Institute (NCI) Bethesda, Maryland, United States
View Trial Details

Related conditions